Midlife stroke risk and cognitive decline: A 10-year follow-up of the Whitehall II cohort study

Autor: Eric J. Brunner, Archana Singh-Manoux, Sara Kaffashian, Séverine Sabia, Mika Kivimäki, Joël Ankri, Aline Dugravot
Přispěvatelé: Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Department of Epidemiology and Public Health, University College of London [London] (UCL), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre de Gérontologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Sainte Perine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), S.K. was funded by a doctoral grant from Region Ile-de-France. A.S.-M. was supported by a European Young Investigator Award from the European Science Foundation and the Na- tional Institute on Aging, National Institutes of Health (R01AG013196, R01AG034454). M.K. was supported by the Academy of Finland, the BUPA Foundation, the National Institutes of Health (R01HL036310, R01AG034454), and the Medical Research Council., SZTAJNBOK, Pascale, Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)
Rok vydání: 2013
Předmět:
Gerontology
Male
Aging
Epidemiology
Cognitive decline
Cohort Studies
0302 clinical medicine
Risk Factors
MESH: Risk Factors
Verbal fluency test
030212 general & internal medicine
Stroke
MESH: Cohort Studies
Framingham Risk Score
MESH: Middle Aged
Health Policy
Smoking
MESH: Follow-Up Studies
Middle Aged
3. Good health
Cognitive test
Framingham Stroke Risk Profile
Psychiatry and Mental health
Vascular risk factors
Cardiovascular Diseases
Female
Psychology
Cohort study
MESH: Smoking
MESH: Diabetes Mellitus
Clinical Neurology
Mid life
MESH: Stroke
03 medical and health sciences
Cellular and Molecular Neuroscience
Developmental Neuroscience
medicine
Diabetes Mellitus
Dementia
Humans
MESH: Humans
MESH: Cardiovascular Diseases
medicine.disease
Confidence interval
MESH: Male
MESH: Cognition Disorders
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Neurology (clinical)
Geriatrics and Gerontology
Cognition Disorders
MESH: Female
030217 neurology & neurosurgery
Follow-Up Studies
Zdroj: Alzheimer's and Dementia
Alzheimer's and Dementia, Elsevier, 2013, 9 (5), pp.572-9. ⟨10.1016/j.jalz.2012.07.001⟩
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.07.001
Popis: Background: Stroke is associated with an increased risk of dementia. However, it is unclear whether risk of stroke in those free of stroke, particularly in nonelderly populations, leads to differential rates of cognitive decline. Our aim was to assess whether risk of stroke in mid life is associated with cognitive decline over 10 years of follow-up. Methods: We studied 4153 men and 1657women (mean age,55.6 years atbaseline) from the Whitehall II study, a longitudinal British cohort study. We used the Framingham Stroke Risk Profile (FSRP), which incorporates age, sex, systolic blood pressure, diabetes mellitus, smoking, prior cardiovascular disease, atrial fibrillation, left ventricular hypertrophy, and use of antihypertensive medication. Cognitive tests included reasoning, memory, verbal fluency, and vocabulary assessed three times over 10 years. Longitudinal associations between FSRP and its components were tested using mixed-effects models, and rates of cognitive change over 10 years were estimated. Results: Higher stroke risk was associated with faster decline in verbal fluency, vocabulary, and global cognition. For example, for global cognition there was a greater decline in the highest FSRP quartile (20.25 of a standard deviation; 95% confidence interval: 20.28 to 20.21) compared withthelowestriskquartile(P5.03).Noassociationwasobservedformemoryandreasoning.Ofthe individual components of FSRP, only diabetes mellitus was associated independently with faster cognitive decline (b 52 0.06; 95% confidence interval, 20.01 to 0.003; P 5.03). Conclusion: Elevated stroke risk at midlife is associated with accelerated cognitive decline over 10 years. Aggregation of risk factors may be especially important in this association. 2013 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. Thisisan openaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Databáze: OpenAIRE